| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 29.696 | 32.578 | 19.107 | 31.030 | 20.636 | 24.646 | 29.541 | 32.243 | 28.829 | 44.567 |
| Total Income - EUR | 30.730 | 32.593 | 19.200 | 35.903 | 25.845 | 24.646 | 30.332 | 32.413 | 28.830 | 45.752 |
| Total Expenses - EUR | 23.196 | 24.588 | 19.327 | 37.874 | 27.776 | 20.110 | 24.562 | 23.721 | 24.429 | 31.214 |
| Gross Profit/Loss - EUR | 7.534 | 8.005 | -127 | -1.971 | -1.931 | 4.537 | 5.769 | 8.693 | 4.401 | 14.538 |
| Net Profit/Loss - EUR | 6.281 | 5.987 | -1.481 | -2.408 | -2.141 | 4.303 | 5.509 | 8.365 | 3.396 | 11.503 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ema Medcorp 28 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 56.275 | 51.013 | 45.640 | 40.453 | 31.738 | 51.669 | 45.037 | 41.475 | 35.676 | 30.452 |
| Current Assets | 48.373 | 19.430 | 18.515 | 12.145 | 11.394 | 12.799 | 9.060 | 8.052 | 16.629 | 6.974 |
| Inventories | 4.240 | 4.178 | 4.218 | 647 | 143 | 623 | 0 | 0 | 0 | 0 |
| Receivables | 43.400 | 14.224 | 13.331 | 4.180 | 4.581 | 3.246 | 4.485 | 314 | 3.512 | 1.546 |
| Cash | 733 | 1.028 | 966 | 7.318 | 6.669 | 8.931 | 4.575 | 7.738 | 13.117 | 5.428 |
| Shareholders Funds | 71.283 | 32.007 | 27.051 | 24.147 | 16.586 | 15.034 | 20.210 | 19.120 | 22.438 | 19.601 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 33.366 | 38.436 | 37.141 | 28.511 | 26.568 | 49.478 | 33.887 | 30.407 | 29.868 | 18.031 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8693 - 8693" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Ema Medcorp 28 Srl